CoreAge Rx vs Nu Image Medical
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Nu Image Medical head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Nu Image Medical
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 54 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Nu Image Medical a bad call — it's best for people comparing compounded injection and tablet formats who obtain the complete multi-month payment and prescription terms before ordering. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Nu Image Medical |
|---|---|---|
| Brief Score | 94/100 (A) | 54/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | From $89/mo; multi-month supply Compounded injections: six-month supply; rapid-dissolve tablets: five-month supply. Full selected-plan payment, dose schedule and renewal quote unconfirmed; not a confirmed single-month purchase. Final-sale policy; cancel auto-bill at least 48 hours before processing. Report defective/damaged products within seven days with proof for replacement; WAYT-less exception is separate. Full price detailsCompounded semaglutide injection or rapid-dissolve tablet offered; complete selected-plan quote unknown; from $89/month attached to six-month injection or five-month tablet supply, full payment and renewal amount unconfirmed |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | From $89/mo; multi-month supply Compounded injections: six-month supply; rapid-dissolve tablets: five-month supply. Full selected-plan payment, dose schedule and renewal quote unconfirmed; not a confirmed single-month purchase. Final-sale policy; cancel auto-bill at least 48 hours before processing. Report defective/damaged products within seven days with proof for replacement; WAYT-less exception is separate. Full price detailsCompounded tirzepatide injection or rapid-dissolve tablet offered; complete selected-plan quote unknown; from $89/month attached to six-month injection or five-month tablet supply, full payment and renewal amount unconfirmed |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises all 50 states with the assigned provider licensed for the patient state; medication and pharmacy-specific availability still need confirmation |
| Brand-name access | Not confirmed | The reviewed semaglutide/tirzepatide products are compounded; a current named branded GLP-1 offer was not established. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Nu Image Medical: From $89/month tied to six-month injections or five-month tablets, not a confirmed one-month purchase. Full charge/renewal unconfirmed; final-sale terms, 48-hour auto-bill notice and seven-day damage-report deadline apply.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.